Early Life Intervention in Pediatrics Supported by E-health - SMOKE
Recruiting · NCT06311162 · Interventional (participants receive a specific treatment) · Lead sponsor: Insel Gruppe AG, University Hospital Bern
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Who can take part
Inclusion criteria
- Age: younger than 6 years
- Exposed to second-hand smoke at home (at least one parent smoking)
- German speaking parent
- All sex and ethnic backgrounds
- Signed informed consent form from parent
- Children live/grow-up in the same household as the parental participant
- Referred by a health care professional (e.g. physician, midwife, nurse, other professions)
Exclusion criteria
- Participation in another study/trial targeting similar outcomes
- Participation in an active smoking cessation programme
Where it is running
1 location listed.
- Department of Paediatrics, Inselspital, Bern University Hospital - Bern, Switzerland